Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob A Cairns

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cell Metabolism|March 7, 2006
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumptionIoanna Papandreou, Rob A Cairns, Lucrezia Fontana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Pharmacologically increased tumor hypoxia can be measured by 18F-Fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104Rob A Cairns, Kevin L Bennewith, Edward E Graves, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
IDH1 deficiency attenuates gluconeogenesis in mouse liver by impairing amino acid utilizationJing Ye, Yu Gu, Feng Zhang, et al.
Leukemia|November 16, 2019
Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AMLZhuo Ren, Mariusz Shrestha, Takashi Sakamoto, et al.
BMC Cancer|June 17, 2017
Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumorsEric Leung, Rob A Cairns, Naz Chaudary, et al.
Haematologica|December 16, 2017
Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomasFrançois Lemonnier, Elsa Poullot, Aurélie Dupuy, et al.
Blood|July 5, 2012
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parametersFrançois Lemonnier, Lucile Couronné, Marie Parrens, et al.
Blood|January 5, 2012
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphomaRob A Cairns, Javeed Iqbal, François Lemonnier, et al.
The Journal of Experimental Medicine|February 10, 2010
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsStefan Gross, Rob A Cairns, Mark D Minden, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2018
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progressionIvano Amelio, Mara Mancini, Varvara Petrova, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cell Metabolism|March 7, 2006
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumptionIoanna Papandreou, Rob A Cairns, Lucrezia Fontana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Pharmacologically increased tumor hypoxia can be measured by 18F-Fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104Rob A Cairns, Kevin L Bennewith, Edward E Graves, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
IDH1 deficiency attenuates gluconeogenesis in mouse liver by impairing amino acid utilizationJing Ye, Yu Gu, Feng Zhang, et al.
Leukemia|November 16, 2019
Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AMLZhuo Ren, Mariusz Shrestha, Takashi Sakamoto, et al.
BMC Cancer|June 17, 2017
Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumorsEric Leung, Rob A Cairns, Naz Chaudary, et al.
Haematologica|December 16, 2017
Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomasFrançois Lemonnier, Elsa Poullot, Aurélie Dupuy, et al.
Blood|July 5, 2012
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parametersFrançois Lemonnier, Lucile Couronné, Marie Parrens, et al.
Blood|January 5, 2012
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphomaRob A Cairns, Javeed Iqbal, François Lemonnier, et al.
The Journal of Experimental Medicine|February 10, 2010
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsStefan Gross, Rob A Cairns, Mark D Minden, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2018
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progressionIvano Amelio, Mara Mancini, Varvara Petrova, et al.
Pageof 3